SEATTLE, May 28, 2021, (MEDGADGET) — Global Antiandrogen Monotherapy Market
Overview:
Antiandrogens are a type of medicines that prevents androgens such as dihydrotestosterone (DHT) and testosterone from mediating their biological effects in the body. In men, these drugs are used to treat hypersexuality, paraphilias, benign prostatic hyperplasia, priapism, pattern hair loss, and prostate cancer. While antiandrogens are used to treat hype, seborrhea, hirsutism, and acne in girls and women.
For More Information, Request Sample Copy Of Business Report: https://www.coherentmarketinsights.com/insight/request-pdf/3810
Drivers:
Rising incidence of prostate cancer worldwide is expected to drive growth of the global antiandrogen monotherapy market over the forecast period. For instance, prostate cancer is the second most common cancer diagnosed in men and the fourth most common cancer, among all, in the world, according to the World Cancer Research Fund.
Moreover, increasing focus towards product approvals is expected to augment growth of the global antiandrogen monotherapy market. For instance, in December 2019, Pfizer Inc. and Astellas Pharma Inc. received the U.S. Food and Drug Administration (FDA) approval for a supplemental New Drug Application (sNDA) for XTANDI (enzalutamide), which is indicated for the treatment of patients with metastatic castration-sensitive prostate cancer (mCSPC).
Tailored Information as per niche requirement:
LIMITED TIME OFFER – Hurry Up!
Exclusive offer!!! Purchase the report at a discounted rate!!!
Get Discount For Buyers UPTO 30% OFF On Any Research Report
Buy Now with Discount for Premium Report 2021: https://www.coherentmarketinsights.com/promo/buynow/3810
Segmentation:
By type:
- Cyproterone Acetate
- Nonsteroidal
- Steroidal
- Bicalutamide
- Flutamide
By Indication:
- Benign Prostatic Hyperplasia
- Hirsutism
- Hyperandrogenism
- Prostate Cancer
- Others
By Distribution channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By region:
- Europe
- North America
- Middle East
- Latin America
- Asia Pacific
- Africa
Regional Insight:
North America and Europe are expected to witness robust growth in the global antiandrogen monotherapy market due to rising incidence of prostate cancer in these regions. For instance, as per the American Society of Clinical Oncology (ASCO), in 2020, approximately 191,930 new cases of prostate cancer were diagnosed in the United States.
To get detailed table of content (ToC), please click – https://www.coherentmarketinsights.com/ongoing-insight/toc/3810
Competitive Section:
Key players active in the global antiandrogen monotherapy market are Astellas Pharma Inc., Pfizer Inc., AstraZeneca Plc., F. Hoffmann-La Roche Ltd., Abbott Laboratories, OSI Pharmaceuticals, Inc., Takeda Pharmaceutical Company Limited, Bristol-Myers Squibb Company, Genentech Inc., Progenics Pharmaceuticals, Inc., Novartis AG, Sanofi SA, GlaxoSmithKline Plc., ALZA Corporation, Amgen Inc., ANI Pharmaceuticals, Inc., and others.
Have a Look at Related Research Insights:
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837